Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Champions Oncology, Inc. - Common Stock
(NQ:
CSBR
)
6.156
-0.004 (-0.06%)
Streaming Delayed Price
Updated: 12:04 PM EDT, Jul 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Champions Oncology, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
December 13, 2022
Via
ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
December 09, 2022
Via
ACCESSWIRE
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
↗
September 16, 2022
Gainers
Via
Benzinga
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 21, 2022
Via
ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
September 08, 2022
Via
ACCESSWIRE
Earnings Scheduled For September 8, 2022
↗
September 08, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its second quarter. • Sono Group (NASDAQ:SEV) is estimated to report earnings for its second...
Via
Benzinga
Earnings Preview For Champions Oncology
↗
September 07, 2022
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022
September 06, 2022
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 21, 2022
Record Annual Revenue of $49.1 Million
From
Champions Oncology, Inc.
Via
AccessWire
A Preview Of Champions Oncology's Earnings
↗
July 20, 2022
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
July 14, 2022
HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
May 31, 2022
HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative...
From
Champions Oncology, Inc.
Via
AccessWire
Earnings Scheduled For July 21, 2022
↗
July 21, 2022
Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on revenue of $7.56 billion.
Via
Benzinga
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
May 03, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Champions Oncology, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Here's How Much You Would Have Made Owning Champions Oncology Stock In The Last 5 Years
↗
March 21, 2022
Champions Oncology (NASDAQ:CSBR) has outperformed the market over the past 5 years by 7.88% on an annualized basis. Buying $1,000 In CSBR: 5 years ago, an investor could have...
Via
Benzinga
Champions Oncology Earnings Perspective: Return On Capital Employed
↗
March 16, 2022
According to Benzinga Pro, during Q3, Champions Oncology (NASDAQ:CSBR) earned $787.00 thousand, a 184.12% increase from the preceding quarter. Champions Oncology also posted a...
Via
Benzinga
Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million
March 15, 2022
HACKENSACK, NJ / ACCESSWIRE / March 15, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Earnings Scheduled For March 15, 2022
↗
March 15, 2022
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi...
Via
Benzinga
Earnings Preview For Champions Oncology
↗
March 14, 2022
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022
March 11, 2022
HACKENSACK, NJ / ACCESSWIRE / March 11, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors
February 15, 2022
HACKENSACK, NJ / ACCESSWIRE / February 15, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates
January 20, 2022
HACKENSACK, NJ / ACCESSWIRE / January 20, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs
January 04, 2022
HACKENSACK, NJ / ACCESSWIRE / January 4, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative pharmacology,...
From
Champions Oncology, Inc.
Via
AccessWire
Looking Into Champions Oncology's Return On Capital Employed
↗
December 14, 2021
According to Benzinga Pro, during Q2, Champions Oncology (NASDAQ:CSBR) earned $277.00 thousand, a 261.05% increase from the preceding quarter. Champions Oncology also posted a...
Via
Benzinga
Champions Oncology Reports Record Quarterly Revenue of $11.8 Million
December 13, 2021
Reported income from operations of $263,000 HACKENSACK, NJ / ACCESSWIRE / December 13, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming...
From
Champions Oncology, Inc.
Via
AccessWire
Earnings Scheduled For December 13, 2021
↗
December 13, 2021
Companies Reporting Before The Bell • Qudian (NYSE:QD) is projected to report quarterly earnings at $0.18 per share on revenue of $56.15 million. Companies...
Via
Benzinga
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
December 06, 2021
HACKENSACK, NJ / ACCESSWIRE / December 6, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), leaders in transformative technology solutions utilized in oncology drug discovery and development will report...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus
October 20, 2021
HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced the opening of a European laboratory located in the renowned...
From
Champions Oncology, Inc.
Via
AccessWire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
September 16, 2021
Gainers Stealth BioTherapeutics (NASDAQ:
Via
Benzinga
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million
September 13, 2021
HACKENSACK, NJ / ACCESSWIRE / September 13, 2021 / Champions Oncology, Inc. (Nasdaq:CSBR), leaders in transformative technology solutions utilized in drug discovery and development, today announced its...
From
Champions Oncology, Inc.
Via
AccessWire
Topics
Earnings
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
